Acrivon Therapeutics, Inc. (ACRV)
2.09
+0.03
(+1.46%)
USD |
NASDAQ |
Aug 31, 16:00
2.05
-0.04
(-1.91%)
After-Hours: 20:00
Acrivon Therapeutics Total Assets (Quarterly) : 99.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 99.09M |
| March 31, 2026 | 107.83M |
| December 31, 2025 | 130.82M |
| September 30, 2025 | 145.30M |
| June 30, 2025 | 158.58M |
| March 31, 2025 | 176.35M |
| December 31, 2024 | 196.59M |
| September 30, 2024 | 214.68M |
| June 30, 2024 | 230.58M |
| March 31, 2024 | 120.52M |
| Date | Value |
|---|---|
| December 31, 2023 | 138.26M |
| September 30, 2023 | 151.09M |
| June 30, 2023 | 160.05M |
| March 31, 2023 | 170.20M |
| December 31, 2022 | 181.23M |
| September 30, 2022 | 87.71M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 106.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.43M |
| Shareholders Equity (Quarterly) | 86.66M |
| Debt to Equity Ratio | 0.0244 |
| Current Ratio | 7.993 |
| Net Debt Paydown Yield | 0.37% |